Sionna Therapeutics Inc
NASDAQ:SION
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sionna Therapeutics Inc
NASDAQ:SION
|
US |
|
China United Network Communications Ltd
SSE:600050
|
CN |
|
P
|
Premium Snacks Nordic AB
STO:SNX
|
SE |
|
Pharmaxis Ltd
ASX:PXS
|
AU |
|
Genmab A/S
NASDAQ:GMAB
|
DK |
|
S
|
Sappi Ltd
JSE:SAP
|
ZA |
|
Oriental Carbon & Chemicals Ltd
NSE:OCCL
|
IN |
|
Nauka-Svyaz' PAO
MOEX:NSVZ
|
RU |
|
Monte Carlo Fashions Ltd
NSE:MONTECARLO
|
IN |
|
Emerald Resources NL
ASX:EMR
|
AU |
|
P
|
Prima Moda SA
WSE:PMA
|
PL |
|
Semler Scientific Inc
NASDAQ:SMLR
|
US |
|
Astaka Holdings Ltd
SGX:42S
|
MY |
|
B
|
Byggma ASA
OSE:BMA
|
NO |
|
Hubei Chutian Smart Communication Co Ltd
SSE:600035
|
CN |
Cash Flow Statement
Cash Flow Statement
Sionna Therapeutics Inc
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
(62)
|
(78)
|
(96)
|
(71)
|
(75)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
4
|
6
|
9
|
12
|
12
|
|
| Other Non-Cash Items |
11
|
13
|
15
|
8
|
11
|
|
| Change in Working Capital |
(3)
|
(5)
|
(7)
|
1
|
(3)
|
|
| Cash from Operating Activities |
(53)
N/A
|
(69)
-31%
|
(87)
-26%
|
(61)
+30%
|
(66)
-8%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(127)
|
(268)
|
(291)
|
(126)
|
(118)
|
|
| Cash from Investing Activities |
(127)
N/A
|
(268)
-111%
|
(291)
-9%
|
(126)
+57%
|
(119)
+6%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
181
|
384
|
384
|
204
|
206
|
|
| Other |
(3)
|
0
|
0
|
(1)
|
0
|
|
| Cash from Financing Activities |
179
N/A
|
381
+113%
|
381
0%
|
203
-47%
|
206
+2%
|
|
| Change in Cash | ||||||
| Net Change in Cash |
(1)
N/A
|
44
N/A
|
2
-94%
|
15
+512%
|
21
+37%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(53)
N/A
|
(69)
-31%
|
(87)
-26%
|
(62)
+29%
|
(67)
-8%
|
|